Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Ceftriaxone-resistant Neisseria gonorrhoeae detected in England, 2015-24: an observational analysis.

Autor: Fifer H; Blood Safety, Hepatitis, STI & HIV Division, United Kingdom Health Security Agency, London, UK., Doumith M; Specialised Microbiology and Laboratories, United Kingdom Health Security Agency, London, UK., Rubinstein L; Hillingdon Integrated Sexual and Reproductive Health, London North West University Healthcare NHS Trust, London, UK., Mitchell L; Sexual Health Department, University Hospitals Plymouth NHS Trust, Plymouth, UK., Wallis M; Sexual Health Department, University Hospitals Plymouth NHS Trust, Plymouth, UK., Singh S; Genito-Urinary Medicine, Barts Health NHS Trust, London, UK., Jagjit Singh G; Directorate of Sexual Health and HIV Medicine, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK., Rayment M; Directorate of Sexual Health and HIV Medicine, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK., Evans-Jones J; Cheshire West and Chester Sexual Health Services, Chester, UK., Blume A; Sexual Health Service, Solent NHS Trust, Portsmouth, UK., Dosekun O; Jefferiss Wing Centre for Sexual Health & HIV, Imperial College Healthcare NHS Trust, London, UK., Poon K; Jefferiss Wing Centre for Sexual Health & HIV, Imperial College Healthcare NHS Trust, London, UK., Nori A; Department of Sexual & Reproductive Health, Guy's and St Thomas' NHS Foundation Trust, London, UK., Day M; Specialised Microbiology and Laboratories, United Kingdom Health Security Agency, London, UK., Pitt-Kendall R; Specialised Microbiology and Laboratories, United Kingdom Health Security Agency, London, UK., Sun S; Blood Safety, Hepatitis, STI & HIV Division, United Kingdom Health Security Agency, London, UK., Narayanan P; Blood Safety, Hepatitis, STI & HIV Division, United Kingdom Health Security Agency, London, UK., Callan E; Blood Safety, Hepatitis, STI & HIV Division, United Kingdom Health Security Agency, London, UK., Vickers A; Specialised Microbiology and Laboratories, United Kingdom Health Security Agency, London, UK., Minshull J; Specialised Microbiology and Laboratories, United Kingdom Health Security Agency, London, UK., Bennet KF; Blood Safety, Hepatitis, STI & HIV Division, United Kingdom Health Security Agency, London, UK., Johnson JEC; Blood Safety, Hepatitis, STI & HIV Division, United Kingdom Health Security Agency, London, UK., Saunders J; Blood Safety, Hepatitis, STI & HIV Division, United Kingdom Health Security Agency, London, UK., Alexander S; Specialised Microbiology and Laboratories, United Kingdom Health Security Agency, London, UK., Mohammed H; Blood Safety, Hepatitis, STI & HIV Division, United Kingdom Health Security Agency, London, UK., Woodford N; Specialised Microbiology and Laboratories, United Kingdom Health Security Agency, London, UK., Sinka K; Blood Safety, Hepatitis, STI & HIV Division, United Kingdom Health Security Agency, London, UK., Cole M; Blood Safety, Hepatitis, STI & HIV Division, United Kingdom Health Security Agency, London, UK.

Publikováno v: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2024 Oct 17. Date of Electronic Publication: 2024 Oct 17.